At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SLXN Silexion Therapeutics Corp
Pre-Mkt 01-29 06:47:08 EST
2.04
-0.05
-2.39%
盘前2.02
-0.02-0.98%
05:45 EST
High2.09
Low2.02
Vol14.37K
Open2.09
D1 Closing2.09
Amplitude3.34%
Mkt Cap6.38M
Tradable Cap5.62M
Total Shares3.13M
T/O29.43K
T/O Rate0.52%
Tradable Shares2.75M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
Silexion Therapeutics Announces Groundbreaking Preclinical Results for SIL204, Demonstrating Near-Complete Inhibition of Pan-KRAS Mutations Across Multiple Cancer Types
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-Kras Activity of Sil204, Demonstrating up to 99.7% Inhibition and First Evidence in Gastric Cancer
Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.